Assessing Multiple Treatment Regimens for Tuberculosis

医学 肺结核 贝叶斯概率 养生 痰 可信区间 内科学 人口 入射(几何) 不利影响 临床终点 结核分枝杆菌 肺结核 后验概率 贝叶斯推理 外科 终点 意向治疗分析 随机对照试验 点估计 相对风险
作者
Hanif Esmail,Nicholas Iain Paton,Jodie Anne Schildkraut,Ilaria Motta,Alexander J. Szubert,Suzanne M. Dufault,Norbert Heinrich,Simon Tiberi,Cissy M Kityo,Timothy Daniel McHugh,Fairoez Ryklief,Daniela María Cirillo,Rodney Dawson,Karen Sanders,Stellah George Mpagama,Lindsay C Thompson,Le Hong Van,Dominic Wakerley,Elena Tudor,Angela M. Crook
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
被引量:1
标识
DOI:10.1056/nejmoa2611913
摘要

MethodsIn this phase 2, randomized, controlled trial, we assigned participants with rifampin-susceptible pulmonary tuberculosis to receive the standard four-drug combination (isoniazid–rifampin–pyrazinamide–ethambutol; HRZE) for 24 weeks; bedaquiline–delamanid–moxifloxacin for 16 weeks; or one of 10 new four-drug combinations for 16 weeks. The new regimens contained ganfeborole, BTZ-043, or both, with combinations of bedaquiline, delamanid, moxifloxacin, pyrazinamide, pretomanid, and linezolid. The primary end point was the log10(time to positivity) slope (rate of change from baseline to week 12 in the time to Mycobacterium tuberculosis growth in a positive sputum culture). The treatment effect was assessed as the Bayesian posterior probability of superiority of each new regimen to HRZE with respect to the primary end point (results were used to select regimens for further evaluation, rather than for characterization of efficacy). ResultsA total of 401 participants underwent randomization; 371 were included in the modified intention-to-treat population and 400 in the safety population. We identified two promising regimens for further evaluation: ganfeborole–bedaquiline–pretomanid–moxifloxacin (BPMG) and BTZ-043–bedaquiline–delamanid–moxifloxacin (BDMT). The log10(time to positivity) slope was 0.129 log10(days) per week (95% Bayesian credible interval, 0.112 to 0.146) with BPMG and 0.142 log10(days) per week (95% Bayesian credible interval, 0.126 to 0.160) with BDMT, as compared with 0.118 log10(days) per week (95% Bayesian credible interval, 0.105 to 0.131) with HRZE, for a relative difference of 9.1% (95% Bayesian credible interval, −8.6 to 29.0) and 20.5% (95% Bayesian credible interval, 2.7 to 41.1), respectively, and a posterior probability of superiority of 0.83 and 0.99. The incidence of adverse events of grade 3 or higher was 38% in the BPMG group (none of the participants discontinued), 28% in the BDMT group (one discontinued because of a drug reaction with eosinophilia and systemic symptoms), and 24% in the HRZE group (none discontinued). Bedaquiline–moxifloxacin–pyrazinamide–BTZ-043 was discontinued because of hepatotoxic effects. ConclusionsIn this trial, two four-drug regimens, one with ganfeborole and one with BTZ-043, showed evidence of potential efficacy and a safety profile that did not preclude progression to further evaluation. (Funded by Innovative Medicines Initiative 2 Joint Undertaking and others; PARADIGM4TB ClinicalTrials.gov number, NCT06114628.)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
外向新梅发布了新的文献求助10
刚刚
刚刚
刚刚
科研通AI2S的应助被难过的煎饼采纳,获得10
1秒前
田様的应助被Karry采纳,获得10
1秒前
思源的应助被嘟嘟大魔王采纳,获得50
1秒前
1秒前
2秒前
2秒前
3秒前
3秒前
ZHENG完成签到,获得积分10
3秒前
3秒前
shenkekeshen的应助被职克琪采纳,获得10
4秒前
YAMABUKI完成签到,获得积分10
4秒前
4秒前
xing_xing的应助被眉间一把刀采纳,获得20
5秒前
5秒前
6秒前
谭小谭发布了新的文献求助10
6秒前
6秒前
芥末很甜完成签到,获得积分10
6秒前
jiajiajia发布了新的文献求助10
7秒前
科目三的应助被韭菜馅采纳,获得10
7秒前
7秒前
春申君发布了新的文献求助10
7秒前
Hugo完成签到,获得积分10
8秒前
ohooo发布了新的文献求助10
8秒前
ku发布了新的文献求助10
8秒前
大模型的应助被FXQ采纳,获得10
8秒前
wddd333333完成签到,获得积分10
8秒前
南楼发布了新的文献求助10
9秒前
9秒前
高铭泽发布了新的文献求助10
10秒前
shuyiWang发布了新的文献求助10
12秒前
儒雅青梦完成签到,获得积分10
12秒前
小鹿飞飞发布了新的文献求助10
12秒前
lvy发布了新的文献求助10
14秒前
甫贤180949174完成签到,获得积分20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509